Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerevel Therapeutics Hldg Inc (NQ: CERE )

34.39 +2.59 (+8.14%)
Streaming Delayed Price Updated: 2:42 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerevel Therapeutics Hldg Inc

< Previous 1 2 3 4 5 Next >
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
Analysts have provided the following ratings for Cerevel Therapeutics Hldg (NASDAQ:CERE) within the last quarter: 
Via Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
Via Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Over the past 3 months, 8 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
  B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading. 
Via Benzinga
Why Cerevel Therapeutics Holdings Shares Are Nosediving
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 6.42% to $25.37 during Tuesday's session after the company reported worse-than-expected third-quarter EPS results and filed... 
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Cerevel Therapeutics Hldg (NASDAQ:CERE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Cerevel Therapeutics
  Cerevel Therapeutics Hldg (NASDAQ:CERE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
Upgrades 
Via Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
Over the past 3 months, 8 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades See all analyst ratings upgrades. 
Via Benzinga
Cerevel Therapeutics Shares Are Falling: Here's Why
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 7.1% to $32.00 during Tuesday's trading session. The company on Friday priced its underwritten common stock offering of 7.25... 
Via Benzinga
Bumble, Hanesbrands, Sonos And Some Other Big Losers From Thursday
U.S. stocks closed mixed on Thursday following the release of PPI data. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
Here's Why Cerevel Therapeutics Stock Is Getting Hammered Today
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower after the company announced a proposed public offering of $250 million of common stock. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.